PERNIX THERAPEUTICS HLDGS IN
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for PERNIX THERAPEUTICS HLDGS IN DEBT 4.250% 4/0, CUSIP 71426VAJ7.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for PERNIX THERAPEUTICS HLDGS IN DEBT 4.250% 4/0, CUSIP 71426VAJ7.